GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human fto in complex with small-molecule inhibitors

Analyse Crystal structure of human fto in complex with small-molecule inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AK4
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-ketoglutarate-dependent dioxygenase FTO,ALPHA- ketoglutarate-dependent dioxygenase…
EC
1.14.11.-
UniProt
Q9C0B1
Ligands
PD9, ZN
Pockets
2 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-ketoglutarate-dependent dioxygenase FTO,ALPHA- ketoglutarate-dependent dioxygenase fto (EC 1.14.11.-)protein42540% helix, 23% strandQ9C0B1

Ligands and binding sites

  • PD9 · (~{E})-2-cyano-~{N},~{N}-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12820.710.8540ZN, PD9
2840.330.7318empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6AK4 · Crystal structure of human FTO in complex with small-molecule inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9C0B1 · AlphaFold monomer V2.0 prediction for alpha-ketoglutarate-dependent dioxygenase fto… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.